GB0916349D0
Pharmaceutical compositions and related methods of delivery
Abstract
This record has no abstract on file.
Term
3 yearsto projected expiry
Projected expiry 17 September 2029, counted from filing; an application has no term until it is granted.
- Priority
- Filed
- Published
- Today
- Projected expiry
96 members in 26 offices
Priority claims3
| Document | Office | Kind | Date |
|---|---|---|---|
| 9771608 | United States of America | P | |
| 14168608 | United States of America | P | |
| 16138709 | United States of America | P |
Members96
| Document | Office | Kind | |
|---|---|---|---|
| GB0916349D0This record | United Kingdom | D0 | |
| AU2009294320A1 | Australia | A1 | |
| CA2737456A1 | Canada | A1 | |
| CA2963659A1 | Canada | A1 | |
| CA3080587A1 | Canada | A1 | |
| WO2010032140A2 | World Intellectual Property Organization (WIPO) | A2 | |
| GB2463978A | United Kingdom | A | |
| US2010105627A1 | United States of America | A1 | |
| WO2010032140A3 | World Intellectual Property Organization (WIPO) | A3 | |
| HK1143072A | Hong Kong, China | A | |
| HK1143072A1 | Hong Kong, China | A1 | |
| MX2011002836A | Mexico | A | |
| KR20110058886A | Republic of Korea | A | |
| IL211799A0 | Israel | A0 | |
| IL211799D0 | Israel | D0 | |
| EP2343982A2 | European Patent Office (EPO) | A2 | |
| CN102176900A | China | A | |
| US2011257095A1 | United States of America | A1 | |
| GB201119686D0 | United Kingdom | D0 | |
| US2012009229A1 | United States of America | A1 | |
| JP2012502973A | Japan | A | |
| GB2482810A | United Kingdom | A | |
| GB2463978B | United Kingdom | B | |
| GB2463978B8 | United Kingdom | B8 | |
| US2012093886A1 | United States of America | A1 | |
| RU2011115060A | Russian Federation | A | |
| US8329198B2 | United States of America | B2 | |
| NZ591810A | New Zealand | A | |
| ZA201101657B | South Africa | B | |
| US8535695B2 | United States of America | B2 | |
| EP2343982A4 | European Patent Office (EPO) | A4 | |
| JP2014074069A | Japan | A | |
| JP5623406B2 | Japan | B2 | |
| US2015031631A1 | United States of America | A1 | |
| AU2009294320B2 | Australia | B2 | |
| RU2552324C2 | Russian Federation | C2 | |
| BRPI0918652A2 | Brazil | A2 | |
| US9265812B2 | United States of America | B2 | |
| JP2016074733A | Japan | A | |
| IL211799A | Israel | A | |
| US2016158159A1 | United States of America | A1 | |
| IL245172A0 | Israel | A0 | |
| IL245172D0 | Israel | D0 | |
| KR101683314B1 | Republic of Korea | B1 | |
| KR20160142408A | Republic of Korea | A | |
| US9566246B2 | United States of America | B2 | |
| EP2343982B1 | European Patent Office (EPO) | B1 | |
| US2017112938A1 | United States of America | A1 | |
| CA2737456C | Canada | C | |
| JP2017088625A | Japan | A | |
| MX348705B | Mexico | B | |
| PT2343982T | Portugal | T | |
| DK2343982T3 | Denmark | T3 | |
| CN106974888A | China | A | |
| LT2343982T | Lithuania | T | |
| ES2629131T3 | Spain | T3 | |
| EP3210474A1 | European Patent Office (EPO) | A1 | |
| SI2343982T1 | Slovenia | T1 | |
| SMT201700304T1 | San Marino | T1 | |
| HRP20170929T1 | Croatia | T1 | |
| CN102176900B | China | B | |
| PL2343982T3 | Poland | T3 | |
| HUE033611T2 | Hungary | T2 | |
| JP6258368B2 | Japan | B2 | |
| KR101814186B1 | Republic of Korea | B1 | |
| CY1119148T1 | Cyprus | T1 | |
| HK1243597A | Hong Kong, China | A | |
| HK1243597A1 | Hong Kong, China | A1 | |
| RU2015112963A | Russian Federation | A | |
| RU2015112963A3 | Russian Federation | A3 | |
| RU2678833C2 | Russian Federation | C2 | |
| US2019038758A1 | United States of America | A1 | |
| JP2019048871A | Japan | A | |
| JP2019048872A | Japan | A | |
| CN106974888B | China | B | |
| CA2963659C | Canada | C | |
| RU2019102221A | Russian Federation | A | |
| IL245172A | Israel | A | |
| IL245172B | Israel | B | |
| IL276157A | Israel | A | |
| IL276157D0 | Israel | D0 | |
| JP6771528B2 | Japan | B2 | |
| EP3210474B1 | European Patent Office (EPO) | B1 | |
| US2020397906A1 | United States of America | A1 | |
| JP2021050240A | Japan | A | |
| EP3861986A1 | European Patent Office (EPO) | A1 | |
| BRPI0918652B1 | Brazil | B1 | |
| US11400159B2 | United States of America | B2 | |
| US2022370621A1 | United States of America | A1 | |
| US2022370622A1 | United States of America | A1 | |
| JP7252934B2 | Japan | B2 | |
| CA3080587C | Canada | C | |
| US11969471B2 | United States of America | B2 | |
| US11986529B2 | United States of America | B2 | |
| MX395136B | Mexico | B | |
| US2025345438A1 | United States of America | A1 |
3 legal events, as 2 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)REGISTERED BETWEEN 20230727 AND 20230802732E | 732E | GB | |
| Standard patents granted in hong kongGrantedGR | GR | HK | |
| Requests to designate patent in hong kongDE | DE | HK |
Numbers
- Application
- 916349
Titles
- English
- Pharmaceutical compositions and related methods of delivery
Classification
- CPC, 68
- A61K9/10
- A61K38/212
- A61K47/44
- A61K9/08
- A61K9/16
- A61K38/095
- A61K9/0031
- A61K9/0053
- A61K9/4858
- A61K9/4866
- A61K9/4891
- A61K38/09
- A61K38/12
- A61K38/14
- A61K38/22
- A61K38/26
- A61K38/27
- A61K38/28
- A61K38/29
- A61K47/12
- A61K47/14
- A61K47/32
- A61K38/08
- A61K9/1623
- A61K31/70
- A61K31/7036
- A61K31/713
- A61K31/721
- A61P1/00
- A61P1/04
- A61P1/10
- A61P1/12
- A61P1/14
- A61P1/16
- A61P1/18
- A61P13/12
- A61P25/00
- A61P27/02
- A61P3/00
- A61P3/04
- A61P31/00
- A61P31/04
- A61P31/14
- A61P31/20
- A61P35/00
- A61P37/00
- A61P5/00
- A61P5/02
- A61P5/06
- A61P5/08
- A61P7/04
- A61P9/00
- A61P9/08
- A61P9/12
- A61P9/14
- A61P3/10
- A61K38/16
- A61K38/2214
- A61K38/30
- A61K38/31
- A61K47/26
- A61K51/083
- A61K51/1045
- A61K47/24
- A61K51/1024
- A61K51/1021
- A61K47/34
- A61K38/00
- IPC, 2
- A61K38 08
- A61K38 095